Fuji Pharma CoFRA:FUP -2.59%88 Pretax Margin % is 3.52% as of Mar. 2026, which is 67% below its 10-year median of 10.64. GuruFocus rates FRA:FUP with a GF Score™ of 88/100 and a GF Value™ of €9.59. The stock has 3 warning signs investors should review. Among 952 Drug Manufacturers companies, Fuji Pharma Co ranks worse than 55.15% on this metric.
The historical rank and industry rank for Fuji Pharma Co's Pretax Margin % or its related term are showing as below:
FRA:FUP'
s Pretax Margin % Range Over the Past 10 Years
Min: 5.12 Med: 10.64 Max: 17.94
Current: 5.12
FRA:FUP's Pretax Margin % is ranked worse than 55.15% of 952
companies
in the Drug Manufacturers industry
Industry Median: 7.295
vs FRA:FUP: 5.12
Fuji Pharma Co (FRA:FUP) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Fuji Pharma Co Pretax Margin % Related Terms
Fuji Pharma Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Fuji Pharma Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Fuji Pharma Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fuji Pharma Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fuji Pharma Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Fuji Pharma Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fuji Pharma Co (FRA:FUP) has a Pretax Margin % of 3.52% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Fuji Pharma Co and its competitors. This is 67% below median its historical median of 10.64. Over the past decade, Fuji Pharma Co's Pretax Margin % has ranged from 5.12 to 17.94. According to the industry distribution chart, Fuji Pharma Co ranks #525 out of 952 companies in the Drug Manufacturers industry, placing it in the top 55.1%.
Is Fuji Pharma Co's Pretax Margin % too high?
Fuji Pharma Co's current Pretax Margin % of 3.52% is 67% below median its 10-year median of 10.64. Over the past 10 years, this metric has ranged from a low of 5.12 to a high of 17.94. The Drug Manufacturers industry median Pretax Margin % is 7.30. Fuji Pharma Co's value of 3.52% is 51.7% below this industry median. Based on the distribution chart, Fuji Pharma Co ranks #525 out of 952 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Fuji Pharma Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Fuji Pharma Co's Pretax Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Fuji Pharma Co ranks #525 out of 952 companies for Pretax Margin %. This places Fuji Pharma Co in the lower half of its industry. The industry median Pretax Margin % is 7.30. Fuji Pharma Co's value of 3.52% is 51.7% below this benchmark. Historically, Fuji Pharma Co's own Pretax Margin % has ranged from 5.12 to 17.94 over the past decade. While the company's 10-year median is 10.64 vs. the industry median of 7.30, Fuji Pharma Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fuji Pharma Co's current Pretax Margin % of 3.52% is 51.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Fuji Pharma Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fuji Pharma Co's current Pretax Margin % is 3.52%, which is 67% below median its own 10-year median of 10.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuji Pharma Co stock overvalued right now?
Fuji Pharma Co (FRA:FUP) has a current Pretax Margin % of 3.52%. The stock's GF Value™ is €9.59, compared to a current price of €11.30 — trading 17.8% above its estimated fair value. The current Pretax Margin % is 3.52%, which is 67% below median its 10-year median of 10.64 and 51.7% below the Drug Manufacturers industry median of 7.30. Fuji Pharma Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Fuji Pharma Co (FRA:FUP), the current Pretax Margin % is 3.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fuji Pharma Co (FRA:FUP) Overvalued in 2026?
Based on GuruFocus' analysis, Fuji Pharma Co stock appears to be overvalued.
The current stock price of €11.30 is trading 17.8% above its estimated GF Value™ of €9.59.
Key valuation signals for FRA:FUP:
Pretax Margin %: 3.52% (67% below median its 10-year median of 10.64)
GF Value™: €9.59 vs. price of €11.30 (17.8% above fair value)
Industry Position: 51.7% below the Drug Manufacturers median (#525 of 952)
No single metric tells the full story. See the FRA:FUP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
88GF Score
Get the complete analysis for FRA:FUP
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:FUP has been successfully added to your 
